Fundz

Akouos, Inc. reported raising $105 Million in an initial SEC Form D filing, from an offering of $105 Million

PRIVATEMar 03, 2020

Amount Raised

$105 Million

$105 Million sold, per SEC Form D (first sale Mar 3, 2020)

Round Type

Venture

BostonBiotechnologyHealth CareGeneticsTherapeutics

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as Akouos, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
  • Phio Pharmaceuticals raised $4.4M on April 14, 2020.
  • Legend Biotech raised $150M on April 7, 2020.
  • Vaxcyte, Inc. raised $110M on April 3, 2020.
  • Dyne Therapeutics raised an undisclosed amount on March 31, 2020.
  • Windtree Therapeutics raised an undisclosed amount (Grant) on March 31, 2020.

Who to call at Akouos, Inc., and when

A new round usually means Akouos, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Akouos, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akouos, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Akouos, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akouos, Inc.

Location

645 Summer Street

Boston, Massachusetts, United States

About

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, Akouos was founded in 2016 by leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akouos, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Akouos, Inc.'s next move

See what Strategic adds

Akouos, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.